Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
personalized treatments
Biotech
Can’t plausible mechanism principles apply to uniQure?
The framework has a high regulatory bar that could make development in certain diseases more challenging than others, an FDA official told Fierce.
Angus Liu
Apr 15, 2026 4:00am
Baby KJ scientist launches personalized CRISPR therapy startup
Jan 9, 2026 8:42am
FDA unveils new pathway to speed custom gene editing therapies
Nov 12, 2025 5:00pm
Invitae launches personalized blood tests to spot cancer relapse
Mar 17, 2022 10:20am
Vineti nets $35M to expand logistics software for cell therapy
Feb 6, 2020 9:18am
Pact Pharma launches a trial of its CAR-T for solid tumors
Jul 22, 2019 9:20am
